Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × rucaparib × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Ovarian Neoplasms 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Prostate Cancer Metastatic 1 Primary Myelofibrosis 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Leiomyosarcoma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1

Interventions

enzalutamide 7 Prednisone 7 cabazitaxel 6 Radiosurgery 6 Docetaxel 5 Androgen Antagonists 4 Abiraterone Acetate 4 XRP6258 2 talazoparib 1 sipuleucel-T 1 rucaparib 1 pembrolizumab 1 olaparib 1 gallium 68 PSMA-11 1 fludrocortisone acetate 1 darolutamide 1 apalutamide 1 Zuclomiphene 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisolone 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 LY3023414 1 Injections 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03413995 2024-10-16

TRIUMPH

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed

12 enrolled 11 charts

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡